RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Abhijit Date to Humans

This is a "connection" page, showing publications Abhijit Date has written about Humans.
Connection Strength

0.350
  1. Yadavalli T, Mallick S, Patel P, Koganti R, Shukla D, Date AA. Pharmaceutically Acceptable Carboxylic Acid-Terminated Polymers Show Activity and Selectivity against HSV-1 and HSV-2 and Synergy with Antiviral Drugs. ACS Infect Dis. 2020 11 13; 6(11):2926-2937.
    View in: PubMed
    Score: 0.035
  2. Date AA, Hanes J, Ensign LM. Nanoparticles for oral delivery: Design, evaluation and state-of-the-art. J Control Release. 2016 10 28; 240:504-526.
    View in: PubMed
    Score: 0.026
  3. Date AA, Destache CJ. Natural polyphenols: potential in the prevention of sexually transmitted viral infections. Drug Discov Today. 2016 Feb; 21(2):333-41.
    View in: PubMed
    Score: 0.025
  4. Date AA, Shibata A, McMullen E, La Bruzzo K, Bruck P, Belshan M, Zhou Y, Destache CJ. Thermosensitive Gel Containing Cellulose Acetate Phthalate-Efavirenz Combination Nanoparticles for Prevention of HIV-1 Infection. J Biomed Nanotechnol. 2015 Mar; 11(3):416-27.
    View in: PubMed
    Score: 0.024
  5. Date AA, Shibata A, Bruck P, Destache CJ. Development and validation of a simple and isocratic reversed-phase HPLC method for the determination of rilpivirine from tablets, nanoparticles and HeLa cell lysates. Biomed Chromatogr. 2015 May; 29(5):709-15.
    View in: PubMed
    Score: 0.023
  6. Date AA, Destache CJ. A review of nanotechnological approaches for the prophylaxis of HIV/AIDS. Biomaterials. 2013 Aug; 34(26):6202-28.
    View in: PubMed
    Score: 0.021
  7. Date AA, Shibata A, Goede M, Sanford B, La Bruzzo K, Belshan M, Destache CJ. Development and evaluation of a thermosensitive vaginal gel containing raltegravir+efavirenz loaded nanoparticles for HIV prophylaxis. Antiviral Res. 2012 Dec; 96(3):430-6.
    View in: PubMed
    Score: 0.020
  8. Date AA, Srivastava D, Nagarsenker MS, Mulherkar R, Panicker L, Aswal V, Hassan PA, Steiniger F, Thamm J, Fahr A. Lecithin-based novel cationic nanocarriers (LeciPlex) I: fabrication, characterization and evaluation. Nanomedicine (Lond). 2011 Oct; 6(8):1309-25.
    View in: PubMed
    Score: 0.019
  9. Date AA, Nagarsenker MS. Parenteral microemulsions: an overview. Int J Pharm. 2008 May 01; 355(1-2):19-30.
    View in: PubMed
    Score: 0.015
  10. Date AA, Joshi MD, Patravale VB. Parasitic diseases: Liposomes and polymeric nanoparticles versus lipid nanoparticles. Adv Drug Deliv Rev. 2007 Jul 10; 59(6):505-21.
    View in: PubMed
    Score: 0.014
  11. Date AA, Patravale VB. Microemulsions: applications in transdermal and dermal delivery. Crit Rev Ther Drug Carrier Syst. 2007; 24(6):547-96.
    View in: PubMed
    Score: 0.014
  12. Sutar Y, Singh SK, Dhoble S, Mali J, Adams J, Yadavalli T, Date AA, Shukla D. Oral Self-Nanoemulsifying System Containing Ionic Liquid of BX795 Is Effective against Genital HSV-2 Infection in Mice. ACS Infect Dis. 2024 01 12; 10(1):93-106.
    View in: PubMed
    Score: 0.011
  13. Yadavalli T, Singh SK, Date AA, Shukla D. Tolerability, pharmacokinetics, and anti-herpetic activity of orally administered BX795. Biomed Pharmacother. 2023 Sep; 165:115056.
    View in: PubMed
    Score: 0.011
  14. Xiao P, Gumber S, Marzinke MA, Hoang T, Myers R, Date AA, Hanes J, Ensign LM, Wang L, Rohan LC, Cone R, Fuchs EJ, Hendrix CW, Villinger F. Hypo-osmolar rectal douche tenofovir formulation prevents simian/human immunodeficiency virus acquisition in macaques. JCI Insight. 2022 12 08; 7(23).
    View in: PubMed
    Score: 0.010
  15. Liu F, Mallick S, O'Donnell TJ, Rouzimaimaiti R, Luo Y, Sun R, Wall M, Wongwiwatthananukit S, Date A, Silva DK, Williams PG, Chang LC. Coumarinolignans with Reactive Oxygen Species (ROS) and NF-?B Inhibitory Activities from the Roots of Waltheria indica. Molecules. 2022 May 19; 27(10).
    View in: PubMed
    Score: 0.010
  16. Chen WN, Shaikh MF, Bhuvanendran S, Date A, Ansari MT, Radhakrishnan AK, Othman I. Poloxamer 188 (P188), A Potential Polymeric Protective Agent for Central Nervous System Disorders: A Systematic Review. Curr Neuropharmacol. 2022; 20(4):799-808.
    View in: PubMed
    Score: 0.010
  17. Patel P, Pol A, Kalaria D, Date AA, Kalia Y, Patravale V. Microemulsion-based gel for the transdermal delivery of rasagiline mesylate: In vitro and in vivo assessment for Parkinson's therapy. Eur J Pharm Biopharm. 2021 Aug; 165:66-74.
    View in: PubMed
    Score: 0.009
  18. Kulkarni M, Potdar S, Date AA, Marfatiya A. In Vitro Release Testing of Acyclovir Topical Formulations Using Immersion Cells. Assay Drug Dev Technol. 2021 Feb-Mar; 19(2):75-84.
    View in: PubMed
    Score: 0.009
  19. Hoang T, Zierden H, Date A, Ortiz J, Gumber S, Anders N, He P, Segars J, Hanes J, Mahendroo M, Ensign LM. Development of a mucoinert progesterone nanosuspension for safer and more effective prevention of preterm birth. J Control Release. 2019 02 10; 295:74-86.
    View in: PubMed
    Score: 0.008
  20. Kates M, Date A, Yoshida T, Afzal U, Kanvinde P, Babu T, Sopko NA, Matsui H, Hahn NM, McConkey DJ, Baras A, Hanes J, Ensign L, Bivalacqua TJ. Preclinical Evaluation of Intravesical Cisplatin Nanoparticles for Non-Muscle-Invasive Bladder Cancer. Clin Cancer Res. 2017 Nov 01; 23(21):6592-6601.
    View in: PubMed
    Score: 0.007
  21. Destache CJ, Mandal S, Yuan Z, Kang G, Date AA, Lu W, Shibata A, Pham R, Bruck P, Rezich M, Zhou Y, Vivekanandan R, Fletcher CV, Li Q. Topical Tenofovir Disoproxil Fumarate Nanoparticles Prevent HIV-1 Vaginal Transmission in a Humanized Mouse Model. Antimicrob Agents Chemother. 2016 06; 60(6):3633-9.
    View in: PubMed
    Score: 0.007
  22. Kovarova M, Council OD, Date AA, Long JM, Nochi T, Nochii T, Belshan M, Shibata A, Vincent H, Baker CE, Thayer WO, Kraus G, Lachaud-Durand S, Williams P, Destache CJ, Garcia JV. Nanoformulations of Rilpivirine for Topical Pericoital and Systemic Coitus-Independent Administration Efficiently Prevent HIV Transmission. PLoS Pathog. 2015 Aug; 11(8):e1005075.
    View in: PubMed
    Score: 0.006
  23. Shibata A, McMullen E, Pham A, Belshan M, Sanford B, Zhou Y, Goede M, Date AA, Date AA, Destache CJ. Polymeric nanoparticles containing combination antiretroviral drugs for HIV type 1 treatment. AIDS Res Hum Retroviruses. 2013 May; 29(5):746-54.
    View in: PubMed
    Score: 0.005
  24. Ursekar BM, Soni PS, Date AA, Nagarsenker MS. Characterization of soy polysaccharide and its in vitro and in vivo evaluation for application in colon drug delivery. AAPS PharmSciTech. 2012 Sep; 13(3):934-43.
    View in: PubMed
    Score: 0.005
  25. Bhattacharjee J, Verma G, Aswal VK, Date AA, Nagarsenker MS, Hassan PA. Tween 80-sodium deoxycholate mixed micelles: structural characterization and application in doxorubicin delivery. J Phys Chem B. 2010 Dec 16; 114(49):16414-21.
    View in: PubMed
    Score: 0.004
  26. Mukherjee S, Date A, Patravale V, Korting HC, Roeder A, Weindl G. Retinoids in the treatment of skin aging: an overview of clinical efficacy and safety. Clin Interv Aging. 2006; 1(4):327-48.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support